Signaturefd, LLC Rubius Therapeutics, Inc. Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.79 - $5.98 $884 - $6,691	-1,119 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$4.25 - $10.4 $3,812 - $9,328	897 Added 404.05%	1,119 $6,000
Q4 2020 Feb 11, 2021	BUY	$4.23 - $8.73 $939 - $1,938	222 New	222 $2,000
Q2 2020 Jul 30, 2020	SELL	$4.01 - $6.88 $449 - $770	-112 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$7.23 - $14.12 $809 - $1,581	112 New	112 $1,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.